The Technical Analyst
Select Language :
Regeneron Pharmaceuticals [REGN]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Regeneron Pharmaceuticals Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: SELL (auto-tracking)

Regeneron Pharmaceuticals is listed at the  Exchange

-0.39% $962.49

America/New_York / 28 mar 2024 @ 16:00


Regeneron Pharmaceuticals: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 103 895 mill
EPS: 34.81
P/E: 27.65
Earnings Date: May 01, 2024
SharesOutstanding: 107.94 mill
Avg Daily Volume: 0.503 mill
RATING 2024-03-28
S-
Strong Buy
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Buy
Return On Asset: Strong Buy
DE: Neutral
P/E: Strong Buy
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE 27.65 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
4.70x
Company: PE 27.65 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$2 409.05
(150.29%) $1 446.56
Date: 2024-03-28
Expected Trading Range (DAY)

$ 944.71 - 980.27

( +/- 1.85%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-13 Murphy Andrew J Buy 20 000 Common Stock
2024-03-13 Murphy Andrew J Sell 14 217 Common Stock
2024-03-14 Murphy Andrew J Sell 182 Common Stock
2024-03-14 Murphy Andrew J Sell 444 Common Stock
2024-03-14 Murphy Andrew J Sell 576 Common Stock
INSIDER POWER
-30.83
Last 100 transactions
Buy: 231 452 | Sell: 437 703

Forecast: 16:00 - $962.48

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $962.48
Forecast 2: 16:00 - $962.48
Forecast 3: 16:00 - $962.48
SCORE
-10.00
Sell
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $962.49 (-0.39% )
Volume 0.447 mill
Avg. Vol. 0.503 mill
% of Avg. Vol 88.74 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Regeneron Pharmaceuticals Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Regeneron Pharmaceuticals Inc

RSI

Intraday RSI14 chart for Regeneron Pharmaceuticals Inc

Last 10 Buy & Sell Signals For REGN

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:34sell$944.13N/AActive
Profile picture for
            Regeneron Pharmaceuticals Inc

REGN

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma;Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration and license agreements with Sanofi; Bayer; Teva Pharmaceutical Industries Ltd.; Mitsubishi Tanabe Pharma Corporation; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Kiniksa Pharmaceuticals, Ltd., as well as has an agreement with the U.S. Department of Health and Human Services, as well as with Zai Lab Limited; Intellia Therapeutics, Inc.; Biomedical Advanced Research Development Authority; and AstraZeneca PLC. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.

Last 10 Buy Signals

Date Signal @
PAXGUSDMar 29 - 01:262 205.00
RLCUSDMar 29 - 01:25$3.95
FILUSDMar 29 - 01:25$9.35
ABTUSDMar 29 - 01:241.981
ALCXUSDMar 29 - 01:19$33.72
HBTCUSDMar 29 - 01:0837 602
ARUSDMar 29 - 01:07$41.90
NULSUSDMar 29 - 01:02$0.868
WAVESUSDMar 29 - 01:01$3.83
NEXOUSDMar 29 - 01:001.330

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.